The Shotlee Journal
Browse Shotlee articles about GLP-1 Medications.
Showing 9 / 934 GLP-1 Medications articles
New research indicates that an oral version of a well-known weight loss medication delivers similar results to its injectable counterpart. However, healthcare professionals emphasize that its intended use should be as a treatment for chronic conditions, rather than a superficial fix.
Research indicates that discontinuing GLP-1 medications around conception or in early pregnancy might carry risks. The study links stopping these drugs to increased gestational weight gain and adverse pregnancy outcomes. Experts emphasize the need for further investigation to fully understand the implications.
The World Health Organization (WHO) has issued new guidelines advocating for the use of GLP-1 drugs in the treatment of obesity. These guidelines suggest that GLP-1 therapies can be used long-term by adults, excluding pregnant women, when combined with intensive behavioral therapy.
A safety alert has been issued in Australia concerning GLP-1 receptor agonists like Ozempic. The alert highlights a potential connection to suicidal thoughts and a possible reduction in the effectiveness of oral contraceptives.
Australia's Therapeutic Goods Administration (TGA) has issued a safety alert concerning Ozempic-style drugs and a potential connection to suicidal thoughts and behaviors. While a direct causal link hasn't been established, the TGA advises patients to immediately inform their healthcare provider if they experience any changes in mood or behavior.
A prominent home services company in the UAE has begun delivering weight-loss medications, indicating the sustained popularity of GLP-1 drugs. This move raises discussions about accessibility and safety when obtaining prescription drugs online.
New research indicates a connection between body composition and brain aging. The study suggests that individuals with more muscle mass and less hidden belly fat tend to have younger-appearing brains, as observed through MRI scans.
The rise of GLP-1 medications is influencing how families celebrate Thanksgiving. With reduced appetites and changing dietary needs, many are finding innovative ways to balance tradition and health during the holidays.
Weight loss injections, initially for diabetes, are now popular for rapid weight loss. However, a doctor reports an increase in hemorrhoid cases among patients using drugs like Mounjaro and Ozempic, citing significant bowel changes and increased straining during exercise.
